Avid Bioservices, Inc.
- Jurisdiction
United States - LEI
549300GRUS3ZMGP8MX22 - ISIN
US05368M1062 (CDMO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Read full profile
Stock price
Fundamentals
- Net revenue
€128.32M - Gross margin
7.7% - EBIT
-€17.38M - EBIT margin
-13.5% - Net income
-€129.69M - Net margin
-101.1%
Statement period: - (published )
Dividends
- Last dividend amount
-
$0.66 - Ex date
-
- Payment date
-
Earnings Calls
Latest earnings call: July 2, 2024